Specification of Drug Substances and Products: Development and Validation of Analytical Methods

Author:   Christopher M. Riley (President of Riley and Rabel Consulting Services, Maryville, MO, USA) ,  Thomas W. Rosanske (Consultatnt, Lee's Summit, MO, USA) ,  George L. Reid (Principal Consultant, Cardinal Health, Kansas City, MO, USA)
Publisher:   Elsevier Health Sciences
Edition:   2nd edition
ISBN:  

9780081028247


Pages:   694
Publication Date:   24 July 2020
Replaced By:   9780443134661
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $580.80 Quantity:  
Add to Cart

Share |

Specification of Drug Substances and Products: Development and Validation of Analytical Methods


Add your own review!

Overview

Full Product Details

Author:   Christopher M. Riley (President of Riley and Rabel Consulting Services, Maryville, MO, USA) ,  Thomas W. Rosanske (Consultatnt, Lee's Summit, MO, USA) ,  George L. Reid (Principal Consultant, Cardinal Health, Kansas City, MO, USA)
Publisher:   Elsevier Health Sciences
Imprint:   Elsevier / The Lancet
Edition:   2nd edition
Weight:   1.540kg
ISBN:  

9780081028247


ISBN 10:   0081028245
Pages:   694
Publication Date:   24 July 2020
Audience:   College/higher education ,  Tertiary & Higher Education
Replaced By:   9780443134661
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Reviews

Author Information

Dr. Christopher Riley is the President of Riley and Rabel Consulting Services. He received a bachelor’s degree in Pharmacy (1977) and PhD degree in Pharmaceutical Chemistry (1980) from the University of Bath, UK. He taught Pharmaceutical Chemistry, at the Universities of Florida (1983-6) and the University of Kansas (1986-94), and was a Vice President at DuPont Merck (1994-2001) and ALZA (a division of J&J) (2001-7). He has coauthored more than 140 book chapters and papers in peer-reviewed journals, as well as 5 books. He has extensive experience in CMC regulatory affairs and the development of all types of dosage forms. Former Director of Business Development at Acceleration Laboratory Services, Incorporated. He has previously held scientific and senior management positions at The Upjohn Company, Marion Laboratories, Marion Merrell Dow, Hoechst Marion Roussel, Quintiles, Eli Lilly, Beckloff Associates, and PPD. He currently serves on a Small Molecule USP Expert Committee.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List